A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Catheters in the Emergency Department
Condition(s) studied
Investigational drug(s) / intervention(s)
question for the prescriber: Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication? The injection of a contrast agent? A second blood draw? For each question, there are three possible answers: Yes? No? Maybe?
Study summary
Peripheral venous catheters are frequently inserted in hospitals, with approximately 25 million placed annually in France (HAS data, 2005). The occluded peripheral venous catheter with extension tubing has become the standard in some emergency departments, offering advantages such as patient mobility, the ability to perform repeated blood draws, and the administration of intravenous medications. A 2018 meta-analysis revealed that one in three devices was unnecessary. The placement of a occluded peripheral venous is associated with a more painful insertion, higher cost, and an increased risk of infection and thromboembolism, and blood samples obtained via the occluded peripheral venous catheter are more often hemolyzed than those obtained by direct venipuncture.
Communication between physicians and nurses is essential to ensure optimal patient care. A brief intervention by the nurse when a physician prescribes a occluded peripheral venous catheter can help clarify the appropriateness of this prescription, which could lead to reduced pain for the patient, time savings for healthcare providers, and material cost savings for the hospital.
Eligibility
Primary outcome measure(s)
- the proportion of obturator catheters placed improperly — day 1
Questions for the prescriber
Trial sites (16)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Amiens | Amiens | France | |
| CHU Angers | Angers | France | |
| Chu Clermont Ferrand | Clermont-Ferrand | France | |
| APHP Henri Mondor | Créteil | France | |
| Ch Dieppe | Dieppe | France | |
| APHP CH Simone Veil | Eaubonne | France | |
| HCL Lyon Sud | Lyon | France | |
| HIA Laveran Marseille | Marseille | France | |
| CHRU Nancy | Nancy | France | |
| CHU Nantes | Nantes | France | |
| APHP Lariboisière | Paris | France | |
| AP HP Pitié Salpétrière | Paris | France | |
| APHP Bichat | Paris | France | |
| APHP St Antoine | Paris | France | |
| CHU de ROUEN | Rouen | France | |
| Chu Toulouse | Toulouse | France |
More University Hospital, Rouen trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07584590 on ClinicalTrials.gov ↗ ← All trials in France